Literature DB >> 16394134

Targeted genome modification via triple helix formation.

Jennifer M Kalish1, Peter M Glazer.   

Abstract

Triplex-forming oligonucleotides (TFOs) that can bind to duplex DNA in a sequence-specific manner are potential tools to achieve targeted gene modification. Initial studies demonstrated the ability of TFOs to deliver mutagenic agents in a DNA site-specific manner. It has also been found that TFOs can induce gene modification in chromosomal DNA via the effect of the triple helix itself. Gene modification with TFOs includes induced recombination between a DNA target and a donor DNA molecule, a process that allows a TFO to exert an effect at a distance from the third-strand binding site. Ongoing efforts to develop chemical modifications on the third strand have increased the number of target sites possible for gene correction and new techniques for TFO delivery are beginning to enhance the biologic effectiveness of these reagents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16394134     DOI: 10.1196/annals.1359.023

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

Review 1.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

2.  Recognition of chromosomal DNA inside cells by locked nucleic acids.

Authors:  Randall Beane; Sylvie Gabillet; Christophe Montaillier; Khalil Arar; David R Corey
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

3.  Intramolecular recombination R-triplex in solution: stabilization by bis-intercalator YOYO.

Authors:  Dmitry N Kaluzhny; Vladimir V Timoshin; Olga F Borisova; Victor B Zhurkin; Vladimir L Florentiev; Anna K Shchyolkina
Journal:  J Biomol Struct Dyn       Date:  2008-12

4.  Dynamic estrogen receptor interactomes control estrogen-responsive trefoil Factor (TFF) locus cell-specific activities.

Authors:  Justine Quintin; Christine Le Péron; Gaëlle Palierne; Maud Bizot; Stéphanie Cunha; Aurélien A Sérandour; Stéphane Avner; Catherine Henry; Frédéric Percevault; Marc-Antoine Belaud-Rotureau; Sébastien Huet; Erwan Watrin; Jérôme Eeckhoute; Vincent Legagneux; Gilles Salbert; Raphaël Métivier
Journal:  Mol Cell Biol       Date:  2014-04-21       Impact factor: 4.272

5.  Prevention of liver fibrosis by triple helix-forming oligodeoxyribonucleotides targeted to the promoter region of type I collagen gene.

Authors:  Subramaniyan Koilan; David Hamilton; Narina Baburyan; Mythili K Padala; Karl T Weber; Ramareddy V Guntaka
Journal:  Oligonucleotides       Date:  2010-09-06

Review 6.  Oligo/polynucleotide-based gene modification: strategies and therapeutic potential.

Authors:  R Geoffrey Sargent; Soya Kim; Dieter C Gruenert
Journal:  Oligonucleotides       Date:  2011-03-21

7.  Human replication protein A melts a DNA triple helix structure in a potent and specific manner.

Authors:  Yuliang Wu; Nina Rawtani; Arun Kalliat Thazhathveetil; Mark K Kenny; Michael M Seidman; Robert M Brosh
Journal:  Biochemistry       Date:  2008-04-15       Impact factor: 3.162

8.  Sequence-specific triple helix formation with genomic DNA.

Authors:  Zhaoyang Ye; Ramareddy V Guntaka; Ram I Mahato
Journal:  Biochemistry       Date:  2007-09-11       Impact factor: 3.162

9.  DNA triplex formation with 5-dimethylaminopropargyl deoxyuridine.

Authors:  David A Rusling; Guomei Peng; Natarajan Srinivasan; Keith R Fox; Tom Brown
Journal:  Nucleic Acids Res       Date:  2009-01-12       Impact factor: 16.971

10.  Site-directed gene mutation at mixed sequence targets by psoralen-conjugated pseudo-complementary peptide nucleic acids.

Authors:  Ki-Hyun Kim; Peter E Nielsen; Peter M Glazer
Journal:  Nucleic Acids Res       Date:  2007-10-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.